Ken Griffin Cytosorbents Corp Call Options Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.7 - $1.01 $7,070 - $10,201
10,100 New
10,100 $7,000
Q3 2023

Nov 14, 2023
SELL
$1.86 - $4.03 $25,854 - $56,017
-13,900 Reduced 86.34%
2,200 $4,000
Q2 2023

Aug 14, 2023
BUY
$2.37 - $3.65 $2,133 - $3,285
900 Added 5.92%
16,100 $57,000
Q1 2023

May 15, 2023
BUY
$1.79 - $4.17 $27,208 - $63,384
15,200 New
15,200 $51,000

Others Institutions Holding CTSO

# of Institutions
55
Shares Held
16.9M
Call Options Held
10.1K
Put Options Held
500
View Full List

About Cytosorbents Corp

CTSO Quotes by TradingView
  • Ticker CTSO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 43,577,400
  • Market Cap $57.5M
  • Description
  • Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...
More about CTSO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email